Chang Bao

1.3k total citations
17 papers, 993 citations indexed

About

Chang Bao is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Chang Bao has authored 17 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Organic Chemistry. Recurrent topics in Chang Bao's work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). Chang Bao is often cited by papers focused on MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). Chang Bao collaborates with scholars based in China, United States and Singapore. Chang Bao's co-authors include Weimin Fan, Weiyang Lou, Liang Xu, Guansheng Zhong, Danni Chen, Bisha Ding, Yi Yan Yang, Jiaying Shen, Jie Pan and Chuan Yang and has published in prestigious journals such as Nature Communications, Biomaterials and Cell Death and Differentiation.

In The Last Decade

Chang Bao

16 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang Bao China 13 587 346 268 220 111 17 993
Guansheng Zhong China 18 686 1.2× 412 1.2× 338 1.3× 288 1.3× 156 1.4× 39 1.3k
Weiyang Lou China 24 1.2k 2.1× 931 2.7× 302 1.1× 261 1.2× 118 1.1× 42 1.8k
Yong-Qiu Mao China 20 596 1.0× 177 0.5× 148 0.6× 43 0.2× 63 0.6× 50 1.1k
Chenxuan Wu China 15 382 0.7× 150 0.4× 85 0.3× 47 0.2× 97 0.9× 32 763
Barbara Dapas Italy 25 936 1.6× 300 0.9× 70 0.3× 29 0.1× 161 1.5× 70 1.6k
Yihua Pei China 19 452 0.8× 157 0.5× 31 0.1× 41 0.2× 155 1.4× 30 783
Sheng‐Xue Xie United States 15 446 0.8× 42 0.1× 97 0.4× 49 0.2× 106 1.0× 36 828
Warangkana Lohcharoenkal Sweden 16 503 0.9× 200 0.6× 54 0.2× 31 0.1× 170 1.5× 28 1.2k
Chao‐Hsuan Chen Taiwan 13 230 0.4× 84 0.2× 52 0.2× 52 0.2× 80 0.7× 41 629
Xiong-Bin Hu China 19 1.1k 1.8× 492 1.4× 37 0.1× 40 0.2× 314 2.8× 34 1.5k

Countries citing papers authored by Chang Bao

Since Specialization
Citations

This map shows the geographic impact of Chang Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Bao more than expected).

Fields of papers citing papers by Chang Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Bao. The network helps show where Chang Bao may publish in the future.

Co-authorship network of co-authors of Chang Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Bao. A scholar is included among the top collaborators of Chang Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Bao. Chang Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Su, Hua, et al.. (2024). Noncoding RNAs in chronic obstructive pulmonary disease: From pathogenesis to therapeutic targets. Non-coding RNA Research. 9(4). 1111–1119.
2.
Ding, Bisha, Chang Bao, Luqi Jin, et al.. (2021). CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death. Frontiers in Oncology. 11. 681683–681683. 13 indexed citations
3.
Chen, Danni, Chang Bao, Feng Zhao, et al.. (2020). Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer. Frontiers in Oncology. 10. 1397–1397. 17 indexed citations
4.
Bao, Chang, Ling-Bo Qian, Chi Xiao, et al.. (2020). Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway. Journal of Cancer. 12(1). 76–88. 48 indexed citations
5.
Wang, Xiaowei, Yiran Zheng, Chang Bao, et al.. (2020). Branched α-helical peptides enhanced antitumor efficacy and selectivity. Biomaterials Science. 8(22). 6387–6394. 6 indexed citations
6.
Bao, Chang, Danni Chen, Yunkun Lu, et al.. (2020). MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1. Cell Death and Disease. 11(8). 618–618. 44 indexed citations
7.
Bao, Chang, Yunkun Lu, Danni Chen, et al.. (2019). Exploring specific prognostic biomarkers in triple-negative breast cancer. Cell Death and Disease. 10(11). 807–807. 61 indexed citations
8.
Yang, Chuan, Weiyang Lou, Guansheng Zhong, et al.. (2019). Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice. Acta Biomaterialia. 94. 268–280. 45 indexed citations
9.
Zhong, Guansheng, Chuan Yang, Shaoqiong Liu, et al.. (2019). Polymers with distinctive anticancer mechanism that kills MDR cancer cells and inhibits tumor metastasis. Biomaterials. 199. 76–87. 65 indexed citations
11.
Chin, Willy, Guansheng Zhong, Qinqin Pu, et al.. (2018). A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset. Nature Communications. 9(1). 917–917. 282 indexed citations
12.
Lou, Weiyang, Jing Chen, Bisha Ding, et al.. (2018). Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Journal of Translational Medicine. 16(1). 266–266. 70 indexed citations
13.
Chen, Danni, Jiaying Shen, Chengyong Du, et al.. (2018). miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells. Cell Death and Disease. 9(2). 188–188. 111 indexed citations
14.
Shen, Jiaying, Chengyong Du, Danni Chen, et al.. (2017). A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance. Cell Death and Differentiation. 25(2). 406–420. 78 indexed citations
15.
Zhong, Guansheng, Junchi Cheng, Zhen Liang, et al.. (2017). Short Synthetic β‐Sheet Antimicrobial Peptides for the Treatment of Multidrug‐Resistant Pseudomonas aeruginosa Burn Wound Infections. Advanced Healthcare Materials. 6(7). 52 indexed citations
16.
Lou, Weiyang, Jin‐Xing Liu, Guansheng Zhong, et al.. (2017). MicroRNAs in cancer metastasis and angiogenesis. Oncotarget. 8(70). 115787–115802. 96 indexed citations
17.
Shu-qin, WU, et al.. (2012). Development of a Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Visual Detection of Porcine Epidemic Diarrhea Virus. Journal of Animal and Veterinary Advances. 11(11). 1897–1900. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026